What Are Precancerous Skin Lesions?
How Does It Work?
Ameluz® contains a photosensitizing agent called aminolevulinic acid (ALA). When applied topically to the affected area, Ameluz® is absorbed by the abnormal cells in the lesion. When exposed to a specific wavelength of light, these cells become highly sensitive and are selectively destroyed, leaving healthy skin tissue unaffected.
Product Highlights
Targeted Treatment: Ameluz® is specifically formulated to target and treat precancerous skin lesions, providing a focused approach to managing these potentially dangerous growths.
Minimally Invasive: The treatment involves the topical application of Ameluz® and subsequent light exposure, making it a minimally invasive alternative to surgical procedures for precancerous lesions.
Clinically Proven: Ameluz® has been clinically tested and demonstrated efficacy in the treatment of precancerous skin lesions, providing a well-established solution for individuals seeking to address these conditions.
Indications
Ameluz® is indicated for the treatment of mild to moderate actinic keratosis (AK), a common type of precancerous skin lesion caused by sun exposure.